Cutaneous sıde-effects of the potential COVID-19 drugs

Ümit Türsen; Belma Türsen; Torello Lotti

doi:10.1111/dth.13476

Cutaneous sıde-effects of the potential COVID-19 drugs

Dermatol Ther. 2020 Jul;33(4):e13476. doi: 10.1111/dth.13476. Epub 2020 May 22.

Authors

Ümit Türsen¹, Belma Türsen², Torello Lotti³

Affiliations

¹ Department of Dermatology, School of Medicine, Mersin University, Mersin, Turkey.
² Department of Health Science, Toros University, Mersin, Turkey.
³ Department of Dermatology, School of Medicine, Marconi University, Rome, Italy.

Abstract

COVID-19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon-beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side-effects of these drugs.

Keywords: COVID-19; dermatology; side-effects; skin.

Publication types

Review

MeSH terms

Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use
Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy*
Coronavirus Infections / epidemiology
Drug-Related Side Effects and Adverse Reactions / epidemiology*
Global Health
Humans
Incidence
Pandemics*
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / epidemiology
SARS-CoV-2
Skin Diseases / chemically induced*
Skin Diseases / epidemiology

Substances

Antiviral Agents